News | December 10, 2013

Surgeon Astronaut Shares Experience of How Microgravity Effects the Body

December 10, 2013 — The human body begins to adapt to microgravity of low Earth orbit shortly after launch, according to surgeon astronaut Lee Morin, M.D., Ph.D., and astronaut mission specialist, NASA Johnson Space Center, Houston. Morin visited the International Space Station in 2002 as part of the STS-110 Atlantis space shuttle crew.
 
"Evolution has not prepared the human body for the space environment. However, the human body does successfully adapt to space,” said Morin at the 40th Annual VEITHsymposium. “These changes begin immediately upon exposure to microgravity, although understanding is confounded by the stresses during launch from the Earth's surface into low Earth orbit. The engineering and physics constraints of rocket science bracket the launch duration to furious eight or nine minutes. Immediately post-insertion, adaptation begins.”
 
Morin shared his experience in space, along with the effects of microgravity on the body's systems. According to Morin, fluid shifts immediately from the lower extremities to the upper part of the body and superficial veins in the neck become engorged. Within the first 15 minutes, up to two-thirds of astronauts suffer from motion sickness that can last up to seven days.
 
The cardiovascular system experiences a number of changes, including increased cardiac output; a 10 to 15 percent plasma volume loss begins immediately along with a 10 percent reduction in erythrocyte mass. 
 
"Fortunately, cardiovascular changes of space do not threaten survival,” said Morin. “There is no increase of arrhythmias in space.”
 
Changes to the musculoskeletal system develop with medium to long-term microgravity exposures. Skeletal muscle atrophies and strength is lost. Bone mineral density is also affected with a loss rate of about 1.5 percent per month from the weight bearing bones. 
 
"Over the past decade we have learned to control these losses with heavy resistive exercise on a daily basis," said Morin.
 
Radiation exposure is the most significant health threat in microgravity. Spacecraft can only be partially shielded from radiation. 
 
"Crew can sense radiation, they often report light flashes within their eyes, usually when eyes are closed pre-sleep," said Morin. 
 
The primary radiation risk to the crew is increased lifetime cancer mortality.
 
For more information: www.veithpress.org, www.veithsymposium.org

Related Content

News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
Subscribe Now